Wearable delivery for large-volume biologics
HEED (High Efficiency Elastomer Diaphragm) is a wearable subcutaneous delivery platform designed for biologics administration beyond the clinic.
Control at delivery
Precise Adaptive Control
Manages pressure, flow rate, and staged volume delivery with consistency.
Patient Convenience
Supports treatment beyond the infusion clinic
Suitable for home, work, and daily life environments.
Pharmaceutical Partnership
A co-development opportunity for biologic therapies requiring subcutaneous delivery.
Designed for pharmaceutical companies, combination product teams, and biologic therapy developers.
Laboratory Systems
Alongside its wearable delivery platforms, Mincle Co develops advanced laboratory systems engineered for in-vitro validation, performance characterization, and product delivery confidence.
Develop Next-Generation
Biologics Delivery
with Mincle Co
Patient-centric wearable
Why HEED is Different
Full-Dose Efficiency
Architecture designed to reduce dead volume and support complete dose delivery.
Designed for Patients
HEED supports biologic delivery beyond the hospital, enabling treatment at home and daily life.
Mincle Co collaborates with pharmaceutical partners to co-develop large-volume biologic delivery systems.
Reduce dead volume
Why It Works
Built with execution in mind.
Proven Engineering
Developed through practical design focused on real-world biologic delivery challenges.
Practical Execution
Translating pharmaceutical requirements into manufacturable, user-focused solutions.
Patented Platform Thinking
A scalable system approach combining delivery performance, adaptability, and integration.
Engineering with Intent
Connecting scientific precision with simplified wearable delivery.
Clinical Wearable Focus
A discreet, patient-friendly design for large-volume biologic delivery.
Purpose-Built Core Platform
Developed for licensing and co-development with pharmaceutical partners.